Video
Carlos Aquino, founder and president of PharmaDiversion LLC, discusses timing of inspections from the Drug Enforcement Administration.
Carlos Aquino, founder and president of PharmaDiversion LLC, discusses timing of inspections from the Drug Enforcement Administration (DEA).
This video was recorded at the 2015 NCPA Annual Convention.
FDA Grants Approval to Generic Extended-Release Memantine/Donepezil and Everolimus